Philip James Wealth Mangement, LLC
Source: SEC Form 13F · as of Mar 2026Philip James Wealth Mangement, LLC holds 17 biotech & pharma companies tracked by BioSniper, totaling $78.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$78.0M
| Company | Shares | Value |
|---|---|---|
| MRKMerck & Co., Inc. | 184,582 | $22.2M |
| JNJJOHNSON & JOHNSON | 84,145 | $20.6M |
| PFEPFIZER INC | 411,774 | $11.6M |
| LLYELI LILLY & Co | 4,295 | $4.0M |
| VTRSViatris Inc | 260,728 | $3.5M |
| AMGNAMGEN INC | 9,051 | $3.2M |
| NVONovo Nordisk A/S | 84,135 | $3.1M |
| JAZZJazz Pharmaceuticals plc | 15,459 | $2.9M |
| GILDGILEAD SCIENCES, INC. | 13,707 | $1.9M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2,570 | $1.1M |
| UTHRUNITED THERAPEUTICS Corp | 1,325 | $786K |
| PMPhilip Morris International Inc | 4,730 | $782K |
| CAHCardinal Health Inc. | 3,082 | $651K |
| OGNOrganon & Co. | 100,796 | $604K |
| ABTABBOTT LABORATORIES | 4,189 | $430K |
| BIIBBIOGEN INC. | 2,323 | $426K |
| MCKMcKesson Corporation | 300 | $260K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.